SLNP-based CDK4- targeted nanotherapy against glioblastoma.
Ghani U, Ghori FK, Qamar MU, Khan H, Azad B, Habib S, Justin S, Khan IN, Shah TA, Shazly GA, Bourhia M, Perveen F, Javed A.
Ghani U, et al. Among authors: habib s.
Front Oncol. 2024 Nov 22;14:1455816. doi: 10.3389/fonc.2024.1455816. eCollection 2024.
Front Oncol. 2024.
PMID: 39650055
Free PMC article.